| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689323 | European Urology | 2017 | 6 Pages |
Abstract
Patients with favorable- and intermediate-prognostic criteria disease treated with third-line targeted therapy have an associated longer overall survival compared with those with poor risk disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
J. Connor Wells, Igor Stukalin, Craig Norton, Sandy Srinivas, Jae Lyun Lee, Frede Donskov, Georg A. Bjarnason, Haru Yamamoto, Benoit Beuselinck, Brian I. Rini, Jennifer J. Knox, Neeraj Agarwal, D. Scott Ernst, Sumanta K. Pal, Lori A. Wood,